Condition: Patients With Irritable Bowel Syndrome With Diarrhea · Sponsor: Lei Yunshang Group
This trial is a randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase II clinical trial. Its purpose is to evaluate the efficacy and safety of Huanghou Zhixie Diwan in subjects with irritable bowel syndrome with diarrhea (Large Intestinal Damp-heat syndrome) after 4 weeks of treatment.
This description comes directly from the study's public registry record.
Yayun Zhang · +86-18251834682 · zhangyayun@lys.cn
Always discuss trial participation with your own doctor first.
| Beijing Traditional Chinese Medicine Hospital, Capital Medical University | Beijing, China | — |
| The First Hospital of Hunan University of Chinese Medicine | Changsha, China | — |
| Daqing People's Hospital | Daqing, China | — |
| GuangDong Second Traditional Chinese Medicine Hospital | Guangzhou, China | — |
| Inner Mongolia Hospital of Traditional Chinese Medicine | Hohhot, China | — |
| Lianyungang Hospital of Traditional Chinese Medicine | Lianyungang, China | — |
| Luoyang First People's Hospital | Luoyang, China | — |
| Luoyang Third People's Hospital | Luoyang, China | — |
| Meihekou Central Hospital | Meihekou, China | — |
| The Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine | Shenyang, China | — |
| Hebei Provincial Hospital of Traditional Chinese Medicine | Shijiazhuang, China | — |
| The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine | Tianjin, China | — |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07721012